Printer Friendly

HEALTHWATCH INC. HIRES NATIONAL SALES MANAGER

 HEALTHWATCH INC. HIRES NATIONAL SALES MANAGER
 BROOMFIELD, Colo., Feb. 14 /PRNewswire/ -- HealthWatch Inc.


(NASDAQ: HEAL) announced today the hiring of Michael Paquin for the position of national sales manager to lead the expansion of an independent manufacturer's rep sales force. This group will sell HealthWatch's new cardiovascular products to the vast physician office market.
 Paquin, who as national sales manager for Fukuda Denshi was directly responsible for the successful development of their physician office sales force, brings with him more than 12 years of directly related experience in management of independent manufacturer's rep organizations and selling of cardiovascular products.
 "We are pleased to attract someone with the experience of Michael Paquin," said Charles P. Spickert, president and chief operating officer of HealthWatch. "Paquin is a proven sales and marketing professional who will put development of our physician sales group on a fast track. In the past, our direct sales representatives were focused only on hospitals and certain specialists -- approximately 25,000 potential customers. Now, development of the physician sales group will allow us to reach more than 150,000 primary care physician offices."
 Based in Broomfield, Colo., HealthWatch Inc. designs, manufactures and markets medical equipment for screening, diagnosis and management of human cardiovascular disease.
 The company stock is traded under the NASDAQ symbol "HEAL."
 -0- 2/14/92
 /CONTACT: Sanford L. Schwartz of HealthWatch Inc., 303-465-2000/
 (HEAL) CO: HealthWatch Inc. ST: Colorado IN: HEA SU: PER


RF -- DV007 -- 0304 02/14/92 15:23 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 14, 1992
Words:245
Previous Article:MONEY SMALL INVESTOR INDEX: SMALL INVESTORS BACK AWAY FROM BONDS STOCKS
Next Article:ABBOTT TO MARKET COMBINATION TEST FOR HIV-1 AND HIV-2
Topics:


Related Articles
HEALTHWATCH ANNOUNCES NEW VP SALES AND MARKETING
HEALTHWATCH BUILDS PHYSICIAN OFFICE MARKET SALES FORCE
HEALTHWATCH INTRODUCES NEW VASCULAR TESTING EQUIPMENT - PAP II
HEALTHWATCH INTRODUCES NEW LIFE SCIENCES MVL CLASSIC
HEALTHWATCH RECEIVES GOLD AESCULAPIUS AWARD IN POLAND
HEALTHWATCH ANNOUNCES NEW HOLTER MONITOR PRODUCT LINE
HEALTHWATCH ANNOUNCES ORGANIZATIONAL CHANGES
HEALTHWATCH ANNOUNCES OFFICER APPOINTMENTS
HEALTHWATCH ANNOUNCES SECOND QUARTER RESULTS
HEALTHWATCH, INC. APPOINTS STEVE LASH TO BOARD OF DIRECTORS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters